J Korean Geriatr Soc.  1999 Jun;3(1):7-14.

Medical Treatment of Rheumatoid Arthritis

Abstract

Rheumatoid arthritis is a chronic inflammatory disease and afflicts approximately 1% of general population. Once considered as a benign non-fatal disease, rheumatoid arthritis is a debilitating condition with a serious physical, emotional, and economic consequences. Life expectancy is reduced among patients with rheumatoid arthritis, and survival rates are comparable to those for three-vessel coronary disease Hodgkin's disease, and diabetes mellitus. For the past 20 years the treatment of rheumatoid arthritis has been developed on pyramid approach, which has had limited success. This led to a move towards using disease modifying antirheumatic drugs early in the disease. Future of rheumatoid arthritis tensive induction therapy, and treatment for resistant disease. This review will be focused on current principles and general guidelines of drugs for the treatment of rheumatoid arthritis.

Keyword

Rheumatoid Arthritis; Treatment; Antirheumatic Drug

MeSH Terms

Antirheumatic Agents
Arthritis, Rheumatoid*
Coronary Disease
Diabetes Mellitus
Hodgkin Disease
Humans
Life Expectancy
Survival Rate
Antirheumatic Agents
Full Text Links
  • JKGS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr